DE602005011661D1 - Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen - Google Patents
Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungenInfo
- Publication number
- DE602005011661D1 DE602005011661D1 DE602005011661T DE602005011661T DE602005011661D1 DE 602005011661 D1 DE602005011661 D1 DE 602005011661D1 DE 602005011661 T DE602005011661 T DE 602005011661T DE 602005011661 T DE602005011661 T DE 602005011661T DE 602005011661 D1 DE602005011661 D1 DE 602005011661D1
- Authority
- DE
- Germany
- Prior art keywords
- prevention
- treatment
- vitamin
- analogue
- bone diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000020084 Bone disease Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical class C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C35/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a non-condensed ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0422929.0A GB0422929D0 (en) | 2004-10-15 | 2004-10-15 | Bioactive vitamin D analogues |
| PCT/BE2005/000146 WO2006039763A1 (en) | 2004-10-15 | 2005-10-17 | Vitamin d3 analogues for the prevention and treatment of bone disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005011661D1 true DE602005011661D1 (de) | 2009-01-22 |
Family
ID=33462778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005011661T Active DE602005011661D1 (de) | 2004-10-15 | 2005-10-17 | Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7704986B2 (de) |
| EP (1) | EP1809599B8 (de) |
| AT (1) | ATE417035T1 (de) |
| DE (1) | DE602005011661D1 (de) |
| GB (1) | GB0422929D0 (de) |
| WO (1) | WO2006039763A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060135491A1 (en) * | 2004-12-06 | 2006-06-22 | Roger Bouillon | Vitamin D3 analog useful for the treatment of osteoporosis |
| US9907758B2 (en) | 2012-01-09 | 2018-03-06 | Panjab University Department Of Biotechnology (Dbt) | Process for preparing solid lipid sustained release nanoparticles for delivery of vitamins |
| ES2536256B2 (es) * | 2013-11-20 | 2016-02-01 | Universidade De Santiago De Compostela | Análogos de vitamina d con interés farmacéutico |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4804502A (en) * | 1988-01-20 | 1989-02-14 | Hoffmann-La Roche Inc. | Vitamin D compounds |
| US5206230A (en) * | 1991-06-05 | 1993-04-27 | Daikin Industries, Ltd. | Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same |
| ATE251133T1 (de) | 1993-07-09 | 2003-10-15 | Theramex | Neue strukturelle vitamin d derivate |
-
2004
- 2004-10-15 GB GBGB0422929.0A patent/GB0422929D0/en not_active Ceased
-
2005
- 2005-10-17 AT AT05806455T patent/ATE417035T1/de not_active IP Right Cessation
- 2005-10-17 DE DE602005011661T patent/DE602005011661D1/de active Active
- 2005-10-17 EP EP05806455A patent/EP1809599B8/de active Active
- 2005-10-17 US US11/577,254 patent/US7704986B2/en not_active Expired - Fee Related
- 2005-10-17 WO PCT/BE2005/000146 patent/WO2006039763A1/en active Application Filing
-
2010
- 2010-03-04 US US12/717,602 patent/US8258126B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20100160455A1 (en) | 2010-06-24 |
| WO2006039763A8 (en) | 2011-09-01 |
| US20080032955A1 (en) | 2008-02-07 |
| GB0422929D0 (en) | 2004-11-17 |
| WO2006039763A1 (en) | 2006-04-20 |
| ATE417035T1 (de) | 2008-12-15 |
| EP1809599B1 (de) | 2008-12-10 |
| US7704986B2 (en) | 2010-04-27 |
| US8258126B2 (en) | 2012-09-04 |
| EP1809599B8 (de) | 2012-04-04 |
| EP1809599A1 (de) | 2007-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE395871T1 (de) | Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen | |
| ATE329587T1 (de) | Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen | |
| HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| DE60223923D1 (de) | Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke | |
| IL185391A0 (en) | Quinazolinone t-type calcium channel antagonists | |
| AU2007257423A8 (en) | Purine analogs | |
| TW200612892A (en) | Novel compounds | |
| EA200901166A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr 119 | |
| MXPA05011523A (es) | Heteroarilos sustituidos como inhibidores de proteinas de tirosina fosfatasas. | |
| DE60317061D1 (de) | Ibandronsäure zur behandlung und vorbeugung von osteoporose | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| IL189104A (en) | Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders. | |
| DE60233261D1 (de) | Inhibitoren von humanem adam-10 | |
| BRPI0514111B8 (pt) | derivados de benzamidina, processo para a preparação destes e composição farmacêutica compreendendo os mesmos | |
| ATE435852T1 (de) | Gpe-analoga und peptidomimetika | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| ATE399758T1 (de) | Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| DE602005011661D1 (de) | Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen | |
| ATE509269T1 (de) | Verfahren und verbindungen zur modulierung von apoptosis | |
| DE60323234D1 (de) | Verwendung von Vitamin C zur Behandlung der Charcot-Marie-Tooth Krankheit | |
| DE60111574D1 (de) | Bisphosphonate-enthaltenden zusammensetzungen zur vorbeugung und/oder heilung von metabolischen knochenkrankheiten, verfahren zu ihren herstellung und benutzung dieser zusammensetzungen | |
| AU2003251728A1 (en) | Placental growth factor as a target for the treatment of osteoporosis | |
| CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| R082 | Change of representative |
Ref document number: 1809599 Country of ref document: EP Representative=s name: MICHALSKI HUETTERMANN & PARTNER PATENTANWAELTE, 40 |